Aehr Test Systems
NASDAQ: AEHR · TECHNOLOGY · SEMICONDUCTOR EQUIPMENT & MATERIALS
Updated 2026-04-29
Aehr Test Systems (AEHR) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for AEHR.
Current price exceeds what fundamentals support. Risk/reward skewed unfavorably.
AEHR historical valuation range
Where current P/E sits in AEHR's own 5Y range.
AEHR intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Standard discounted cash flow models produce unreliable output for unprofitable or near-breakeven companies. Revenue-based multiples such as P/S and EV/Sales, combined with the historical valuation position above, give a more reliable read for this stock.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
AEHR valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
P/S Ratio — History
Current: 56.86x
Is AEHR overvalued in 2026?
Aehr Test Systems (AEHR) currently trades at $81.81 per share with a market capitalization of $2,573,191,000.00. Based on our multi-factor framework, the stock appears richly valued with a Smart Value Score of 26/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
AEHR currently has no meaningful P/E ratio, which typically signals that the company is unprofitable, near breakeven, or emerging from a loss-making period. With a P/S ratio of 56.9x, the market is valuing the company primarily on its revenue rather than its earnings.
Looking at its own history, AEHR is currently trading cheaper than 100% of the last 5Y on P/E. This places it in the 0th percentile of its historical range, a level that has historically coincided with attractive entry points.
A standard DCF model does not produce reliable output for AEHR under current conditions. For unprofitable or near-breakeven companies, revenue-based multiples such as EV/Sales and historical P/S percentile are more informative than intrinsic value calculations.
Financial quality is a concern. The Piotroski F-Score of 2/9 flags weakening fundamentals that deserve closer scrutiny before the valuation case can be fully trusted.
Bottom line: AEHR appears richly valued on our framework, with a Smart Value Score of 26/100. At current levels the risk/reward is skewed against the buyer. A materially lower price or significant operational improvement would be needed to change the picture.
Frequently asked questions
Is AEHR overvalued in 2026?
Based on a Smart Value Score of 26/100, AEHR appears overvalued. Current price exceeds what fundamentals currently justify.
What is AEHR's fair value?
Standard DCF is unreliable for AEHR due to its current profitability profile. Revenue-based approaches such as EV/Sales or historical P/S percentile are more informative for this stock.
What P/E ratio does AEHR trade at?
AEHR does not have a meaningful P/E ratio at this time, typically a sign of unprofitability or an ongoing earnings transition.
Is AEHR a buy based on valuation?
WallStSmart does not issue buy or sell recommendations. Our Smart Value Score of 26/100 reflects the combined read on growth, quality, and price. The profile skews cautious. Consider waiting for a better price or clearer operational improvement.
How does AEHR's valuation compare to its history?
On P/E, AEHR currently sits in the 0th percentile of its own 5Y range. That is historically cheap relative to where it has traded over the period.
What is AEHR's Smart Value Score?
AEHR's Smart Value Score is 26/100. The Smart Value Score is a proprietary WallStSmart metric blending growth quality, financial health, and valuation attractiveness into a single 0-100 read. Scores above 75 are rare and indicate strong multi-factor alignment.